AI Support for Mental Health Conditions

N/A

Waitlist Available

Research Sponsored by Eleos Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be adults

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months before and 6 month after study start date

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if an AI platform can help case managers in a mental health and substance use disorder health system. They want to know if the AI platform is easy to use and if it helps

Who is the study for?

This trial is for case managers working in a nonprofit health system that deals with mental health and substance use disorders. They will be using an AI platform to manage around 250 adult clients. To participate, these case managers should be currently active and providing case management services.

What is being tested?

The study is testing the impact of an AI platform on the productivity and satisfaction of case managers dealing with traumatic stress, depression, anxiety, and substance use disorders. It compares their performance before and after implementing this technology.

What are the potential side effects?

Since this trial involves the use of an AI tool rather than a medical treatment, traditional side effects are not applicable. However, potential 'side effects' could include changes in workflow or job satisfaction among case managers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months before and 6 month after study start date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months before and 6 month after study start date

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months before and 6 month after study start date for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Case manager note completion time

Case manager productivity

Case manager satisfaction

Secondary study objectives

Clients' crisis services utilization

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Artificial Intelligence (AI)Experimental Treatment1 Intervention

Once randomized to start using the AI-based platform for documenting their services, providers will have access to the Eleos Health platform, a secure and HIPAA-compliant tool specifically designed for documenting behavioral health encounters. This AI-powered platform enables providers to complete progress notes more quickly. Providers will complete the progress notes on their phones, and these notes will be integrated into the client's electronic health records.

Group II: Services-as-usual (SAU)Active Control1 Intervention

During the services-as-usual (SAU) phase of this study, providers will deliver the routine case management services offered by Centerstone and report these services in the usual way they do.

0 / 1Eligibility criteria met